Cystic fibrosis HRCT scores correlate strongly with pseudomonas infection

Pediatric Pulmonology

Volumn 44, Issue 11, 2009, Pages 1107-1117

  Robinson, Terry E ^a   Leung, Ann N ^a   Chen, Xiaorong ^b   Moss, Richard B ^a   Emond, M J ^c  

^a STANFORD UNIVERSITY MEDICAL CENTER   (United States)

^b STANFORD UNIVERSITY   (United States)

^c UNIVERSITY OF WASHINGTON   (United States)

Author keywords

Chest HRCT; Cystic fibrosis; Pseudomonas infection; Pulmonary function

Indexed keywords

ADOLESCENT; ARTICLE; BACTERIUM CULTURE; BODY MASS; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE EXACERBATION; FEMALE; HIGH RESOLUTION COMPUTER TOMOGRAPHY; HUMAN; LUNG FIBROSIS; LUNG FUNCTION TEST; MALE; MORTALITY; NONHUMAN; OUTCOME ASSESSMENT; PRESCHOOL CHILD; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA; PSEUDOMONAS INFECTION; SCHOOL CHILD; THORAX RADIOGRAPHY;

ADOLESCENT; BODY MASS INDEX; CHILD; CROSS-SECTIONAL STUDIES; CYSTIC FIBROSIS; FEMALE; FORCED EXPIRATORY VOLUME; HUMANS; MALE; PSEUDOMONAS INFECTIONS; ROC CURVE; TOMOGRAPHY, X-RAY COMPUTED;

EID: 72449162602     PISSN: 87556863     EISSN: 10990496     Source Type: Journal    
DOI: 10.1002/ppul.21107     Document Type: Article

References (43)

1. Stiglbauer R, Schurawitzki H, Eichler I, Vergesslich KA, Götz M. High resolution CT in children with cystic fibrosis. Acta Radiol 1992;33:548-553.
2. Helbich TH, Heinz-Peer G, Fleischmann D, Wojnarowski C, Wunderbaldinger P, Huber S, Eichler I, Herold CJ. Evolution of CT findings in patients with cystic fibrosis. Am J Roentgenol 1999;173:81-88. (Pubitemid 29291094)
3. Maffessanti M, Candusso M, Brizzi F, Piovesana F. Cystic fibrosis in children: HRCT findings and distribution of disease. J Thorac Imaging 1996;11:27-38. (Pubitemid 126443567)
4. Long FR, Williams RS, Castile RG. Structural airway abnormalities in infants and young children with cystic fibrosis. J Pediatr 2004;144:154-161. (Pubitemid 38869388)
5. Martinez TM, Llapur CJ, Williams TH, Coates C, Gunderman R, Cohen MD, Howenstine MS, Saba O, Coxson HO, Tepper RS. High-resolution computed tomography imaging of airway disease in infants with cystic fibrosis. Am J Respir Crit Care Med 2005; 172:1133-1138. (Pubitemid 43066649)
6. de Jong PA, Nakano Y, Lequin MH, Mayo JR, Woods R, Pare PD, Tiddens HA. Progressive damage on high resolution computed tomography despite stable lung function in cystic fibrosis. Eur Respir J 2004;23:93-97. (Pubitemid 38088503)
7. de Jong PA, Nakano Y, Hop WC, Long FR, Coxson HO, Pare PD, Tiddens HA. Changes in airway dimensions on computed tomography scans of children with cystic fibrosis. Am J Respir Crit Care Med 2005;172:218-224. (Pubitemid 40981197)
8. de Jong PA, Lindblad A, Rubin L, Hop WC, de Jongste JC, Brink M, Tiddens HA. Progression of lung disease on computed tomography and pulmonary function tests in children and adults with cystic fibrosis. Thorax 2006;61:80-85. (Pubitemid 43106983)
9. Brody AS, Kosorok MR, Li Z, Broderick LS, Foster JL, Laxoya A, Bandla H, Farrell PM. Reproducibility of a scoring system for computed tomography scanning in cystic fibrosis. J Thorac Imaging 2006;21:14-21.
10. Brody AS, Sucharew H, Campbell JD, Millard SP, Molina PL, Klein JS, Quan J. Computed tomography correlates with pulmonary exacerbations in children with cystic fibrosis. Am J Respir Crit Care Med 2005;172:1128-1132. (Pubitemid 43066648)
11. Gibson RL, Burns JL, Ramsey BW. Pathophysiology and management of pulmonary infections in cystic fibrosis. Am J Respir Crit Care Med 2003;168:918-951. (Pubitemid 37267172)
12. Rosenfeld M, Ramsey BW, Gibson RL. Pseudomonas acquisition in young patients with cystic fibrosis: pathophysiology, diagnosis, and management. Curr Opin Pulm Med 2003;9: 492-497. (Pubitemid 37268213)
13. Treggiari MM, Rosenfeld M, Retsch-Bogart G, Gibson R, Ramsey B. Approach to eradication of initial Pseudomonas aeruginosa infection in children with cystic fibrosis. Pediatr Pulmonol 2007;42:751-756. (Pubitemid 47580800)
14. Welsh MJ, Ramsey BW, Accurso FJ, Cutting GR. Cystic fibrosis. In: Scriver CR, Beaudet AL, Sly WS, Valle D, editors. The metabolic basis of inherited diseases. New York: McGraw-Hill; 2001. pp. 521-588.
15. Gibson RL, Emerson J, Mayer-Hamblett N, Burns JL, McNamara S, Accurso FJ, Konstan MW, Chatfield BA, Resch-Bogart G, Waltz DA, Acton J, Zeitlin P, Hiatt P, Moss R, Willimas J, Ramsey BW. Duration of treatment effect after tobramycin solution for inhalation in young children with cystic fibrosis. Pediatr Pulmonol 2007;42:610-623. (Pubitemid 47022973)
16. Ratjen F, Walter H, Haug M, Meisner C, Grasemann H, Doring G. Diagnostic value of serum antibodies in early Pseudomonas aeruginosa infection in cystic fibrosis patients. Pediatr Pulmonol 2007;42:249-255. (Pubitemid 46417698)
17. Emerson J, Rosenfeld M, McNamara S, Ramsey B, Gibson RL. Pseudomonas aeruginosa and other predictors of mortality and morbidity in young children with cystic fibrosis. Pediatr Pulmonol 2002;34:91-100. (Pubitemid 34809519)
18. Robinson TE, Leung AN, Northway WH, Blankenberg FG, Chan FP, Bloch DA, Holmes TH, MOss RB. Composite spirometriccomputed tomography outcome measure in early cystic fibrosis lung disease. Am J Respir Crit Care Med 2003;168:588-593.
19. Robinson TE, Goris ML, Zhu HJ, Chen X, Bhise P, Sheikh F, Moss RB. Dornase alfa reduces air trapping in children with mild cystic fibrosis lung disease: a quantitative analysis. Chest 2005; 128:2327-2335. (Pubitemid 41507576)
20. Robinson TE, Leung AN, Moss RB, Blankenberg FG, Al- Dabbagh H, Northway WH. Standardized high-resolution CT of the lung using a spirometer-triggered electron beam CT scanner. Am J Roentgenol 1999;172:1636-1638.
21. Wang X, Dockery DW, Wypij D, Fay ME, Ferris BG. Pulmonary function between 6 and 18 years of age. Pediatr Pulmonol 1993; 15:75-88.
22. Kulich M, Rosenfeld M, Campbell J, Kronmal R, Gibson RL, Goss CH, Ramsey B. Disease-specific reference equations for lung function in patients with cystic fibrosis. Am J Respir Crit Care Med 2005;172:885-891. (Pubitemid 41369073)
23. Brasfield D, Hicks G, Soong S, Tiller RE. The chest roentgenogram in cystic fibrosis: a new scoring system. Pediatrics 1979; 63:24-29. (Pubitemid 9111195)
24. National Council on Radiation Protection [NCRP] Report 93, 1987.
25. Robinson TE, Leung AN, Northway WH, Blankenberg FG, Bloch DA, Oehlert JW, Al-Dabbagh H, Hubli S, Moss RB. Spirometertriggered high-resolution computed tomography and pulmonary function measurements during an acute exacerbation in patients with cystic fibrosis. J Pediatr 2001;138:553-559. (Pubitemid 32319730)
26. Brody AS, Klein JS, Molina PL, Quan J, Bean JA, Wilmott RW. High-resolution computed tomography in young patients with cystic fibrosis: distribution of abnormalities and correlation with pulmonary function tests. J Pediatr 2004;145:32-38. (Pubitemid 38962449)
27. de Jong PA, Tiddens HA. Cystic fibrosis specific computed tomography scoring. Proc Am Thorac Soc 2007;4:338-342. (Pubitemid 47330867)
28. Farrell PM, Li Z, Kosorok MR, Laxova A, Green CG, Collins J, Lai HC, Makholm LM, Rock MJ, Splaingard ML. Longitudinal evaluation of bronchopulmonary disease in children with cystic fibrosis. Pediatr Pulmonol 2003;36:230-240. (Pubitemid 37055971)
29. Li Z, Kosorok MR, Farrell PM, Laxova A, West SE, Green CG, Collins J, Rock MJ, Splaingard ML. Longitudinal development of mucoid Pseudomonas aeruginosa infection and lung disease progression in children with cystic fibrosis. JAMA 2005;293: 581-588. (Pubitemid 40171240)
30. Cystic Fibrosis Foundation. Clinical practice guidelines for cystic fibrosis. Bethesda, MD; Cystic Fibrosis Foundation; 1997.
31. Obuchowski NA. Receiver operating characteristic curves and their use in radiology. Radiology 2003;229:3-8. (Pubitemid 37152094)
32. Greenland S. Modeling and variable selection in epidemiologic analysis. Am J Public Health 1989;79:340-349. (Pubitemid 19077878)
33. Mayer-Hamblett N, Ramsey BW, Kronmal RA. Advancing outcome measures for the new era of drug development in cystic fibrosis. Proc Am Thorac Soc 2007;4:370-377. (Pubitemid 47330874)
34. Prentice RL. Surrogate endpoints in clinical trials: definition and operational criteria. Stat Med 1989;8:431-440. (Pubitemid 19105891)
35. Kerem E, Corey M, Gold R, Levison H. Pulmonary function and clinical course in patients with cystic fibrosis after pulmonary colonization with Pseudomonas aeruginosa. J Pediatr 1990;116: 714-719. (Pubitemid 20162819)
36. Henry RL, Mellis CM, Petrovic L. Mucoid Pseudomonas aeruginosa is a marker of poor survival in cystic fibrosis. Pediatr Pulmonol 1992;12:158-161.
37. Demko CA, Byard PJ, Davis PB. Gender differences in cystic fibrosis: Pseudomonas aeruginosa infection. J Clin Epidemiol 1995;48:1041-1049.
38. Nixon GM, Armstrong DS, Carzino R, Carlin JB, Olinsky A, Robertson CF, Grimwood K. Clinical outcome after early Pseudomonas aeruginosa infection in cystic fibrosis. J Pediatr 2001;138:699-704. (Pubitemid 32417671)
39. Konstan MW, Morgan WJ, Butler SM, Pasta DJ, Craib ML, Silva SJ, Stokes DC, Wohl ME, Wagener JS, Regelmann WE, Johnson CA. Risk factors for rate of decline in forced expiratory volume in one second in children and adolescents with cystic fibrosis. J Pediatr 2007;151:134-139, 139 e131.
40. Emond M. Statistical power, reproducibility, and accuracy considerations for computed tomography scores as an endpoint in cystic fibrosis clinical trials. Proc Am Thorac Soc 2007;4:E1-E6.
41. Robinson TE. Computed tomography scanning techniques for the evaluation of cystic fibrosis lung disease. Proc Am Thorac Soc 2007;4:310-315. (Pubitemid 47330862)
42. Kozlowska WJ, Bush A, Wade A, Aurora P, Carr SB, Castle RA, Hoo AF, Lum S, Price J, Ranganathan S, Saunders C, Stanojevic S, Stroobant J, Wallis C, Stocks J. Lung function from infancy to the preschool years after clinical diagnosis of cystic fibrosis. Am J Respir Crit Care Med 2008;178:42-49. (Pubitemid 351919192)
43. Fuller W. Measurement error models. New York: John Wiley & Sons; 1987.